Enable Biosciences
Dr. Embers’ research is centered on three major foci: (1) evaluating antibiotic efficacy against Lyme disease; (2) identifying treatments that can eradicate B. burgdorferi infection; and (3) immunodiagnosis for B. burgdorferi infection and cure. The first research goal is to examine, using xenodiagnosis, the efficacy of antibiotic treatment during disseminated B. burgdorferi infection in the nonhuman primate model of Lyme disease. She also serves on the board of the Bay Area Lyme Foundation.
This person is not in the org chart
This person is not in any offices
Enable Biosciences
Enable Biosciences is a South San Francisco-based diagnostics company. They develop ultrasensitive immunoassays that permit early detection and treatment of autoimmune and infectious diseases.